Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization

Sun,Jie; Tu,Min; Han,Bei; Xue,Xiaofeng; Zhang,Ye; Wei,Jishu; Chen,Jianmin; Lu,Zipeng; An,Yong; Cai,Baobao; Lv,Nan; Jiang,Kuirong; Miao,Yi; Gao,Wentao

doi:10.3892/ijo.2013.1919

Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization

Authors:
- Jie Sun
- Min Tu
- Bei Han
- Xiaofeng Xue
- Ye Zhang
- Jishu Wei
- Jianmin Chen
- Zipeng Lu
- Yong An
- Baobao Cai
- Nan Lv
- Kuirong Jiang
- Yi Miao
- Wentao Gao
View Affiliations

Affiliations: Laboratory of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, P.R. China, Department of Endocrinology, Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, P.R. China, Department of General Surgery, The First Affiliated Hospital of Suzhou University, Suzhou, P.R. China, Department of General Surgery, Wuxi People's Hospital, Wuxi, P.R. China, Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, P.R. China
Published online on: April 24, 2013 https://doi.org/10.3892/ijo.2013.1919
Pages: 255-261

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vasohibin-2 was recently identified as an important pro-angiogenesis factor in solid tumor and intracellular localization of its variants is important for elucidating the downstream mechanism(s) of its effects. Currently there are no reported antibodies affordable for intracellular localization. The aim of this study was to generate and characterize polyclonal antibodies against Vasohibin-2 and to determine the intracellular localization of Vasohibin-2. In this study, two polypeptides were synthesized and one prokaryotic Vasohibin-2 recombinant protein was custom-made. New Zealand rabbits were immunized with the polypeptide mixture and prokaryotic recombinant protein, respectively. The purified antibodies from the antiserum were validated by ELISA, western blotting (WB), immunofluorescence (IF), immunohistochemistry (IHC) and immunoprecipitation (IP). In order to determine intracellular localization, the cytoplasmic and nuclear proteins of the human liver cancer cell line HepG2 were isolated for the detection of Vasohibin-2 by western blotting. Vasohibin-2 cDNA, coding for 311 and 355 amino acid residues, fused with or without a DDK/V5 tag at the c-terminus, respectively, was cloned into the Lv-CMV-EGFP vector. Lentiviruses were successfully packaged. Vasohibin-2-overexpressing HepG2-VASH2 (355 amino acid residues) and HepG2-VASH2-V5 (311 amino acid residues fused with V5 tag at the c-terminus) human liver cancer cell lines were established. Approximately 1-2x106 HepG2, HepG2-VASH2 and HepG2-VASH2-V5 cells were injected subcutaneously into the flanks of BALB/c nude mice. Xenograft tumors were harvested for immunohistochemistry. HepG2 cells were transiently transfected with the Lv-CMV-EGFP vectors containing Vasohibin-2 cDNA (coding for 311/355 amino acid residues with a DDK tag at the c-terminal), followed by anti-DDK immunofluorescence. The antibodies obtained were able to detect human VASH2 successfully as applied in western blotting, IF, IHC and IP. Results from IF, IHC and WB (post cytoplasmic/nuclear protein isolation) showed a quite different intracellular localization of VASH2 protein. The VASH2 (with 355 amino acid residues) was located in the cytoplasm while VASH2 (with 311 amino acid residues) was located in the nucleus. The former was found to be a relatively low abundance protein. We successfully generated three rabbit anti-human Vasohibin-2 polyclonal antibodies which can be used for western blotting, IF, IP and IHC. These antibodies will provide a convenient tool for further studies on Vasohibin-2. This is the first study to report differences in the intracellular localization of the VASH2 protein and, hence, a new research direction on the study of VASH2.

View Figures

View References

1.	Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, Sonoda H, Ohta H, Fujiwara T, Shimosegawa T and Sato Y: Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood. 113:4810–4818. 2009. View Article : Google Scholar : PubMed/NCBI
2.	Shibuya T, Watanabe K, Yamashita H, Shimizu K, Miyashita H, Abe M, Moriya T, Ohta H, Sonoda H, Shimosegawa T, Tabayashi K and Sato Y: Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vase Biol. 26:1051–1057. 2006. View Article : Google Scholar : PubMed/NCBI
3.	Sato Y and Sonoda H: The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler Thromb Vase Biol. 27:37–41. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Shen Z, Kauttu T, Seppanen H, Vainionpaa S, Ye Y, Wang S, Mustonen H and Puolakkainen P: Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs. Med Oncol. 29:2718–2726. 2012. View Article : Google Scholar : PubMed/NCBI
5.	Sato Y: The vasohibin family: novel regulators of angiogenesis. Vascul Pharmacol. 56:262–266. 2012. View Article : Google Scholar : PubMed/NCBI
6.	Abe M and Sato Y: cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis. 4:289–298. 2001. View Article : Google Scholar : PubMed/NCBI
7.	Watanabe K, Hasegawa Y, Yamashita H, Shimizu K, Ding Y, Abe M, Ohta H, Imagawa K, Hojo K, Maki H, Sonoda H and Sato Y: Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest. 114:898–907. 2004. View Article : Google Scholar : PubMed/NCBI
8.	Shimizu K, Watanabe K, Yamashita H, Abe M, Yoshimatsu H, Ohta H, Sonoda H and Sato Y: Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun. 327:700–706. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y and Makino H: Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes. 58:2365–2375. 2009. View Article : Google Scholar : PubMed/NCBI
10.	Shirasuna K, Kobayashi A, Nitta A, Nibuno S, Sasahara K, Shimizu T, Bollwein H and Miyamoto A: Possible action of vasohibin-1 as an inhibitor in the regulation of vascularization of the bovine corpus luteum. Reproduction. 143:491–500. 2012. View Article : Google Scholar : PubMed/NCBI
11.	Tamaki K, Moriya T, Sato Y, Ishida T, Maruo Y, Yoshinaga K, Ohuchi N and Sasano H: Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci. 100:88–94. 2009. View Article : Google Scholar : PubMed/NCBI
12.	Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, Sasano H, Yaegashi N and Sato Y: Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas. Cancer Sci. 102:446–451. 2011. View Article : Google Scholar : PubMed/NCBI
13.	Nimmagadda S, Geetha-Loganathan P, Prols F, Scaal M, Christ B and Huang R: Expression pattern of Vasohibin during chick development. Dev Dyn. 236:1358–1362. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Naito H, Kidoya H, Sato Y and Takakura N: Induction and expression of anti-angiogenic vasohibins in the hematopoietic stem/progenitor cell population. J Biochem. 145:653–659. 2009. View Article : Google Scholar : PubMed/NCBI
15.	Xue X, Gao W, Sun B, Xu Y, Han B, Wang F, Zhang Y, Sun J, Wei J, Lu Z, Zhu Y, Sato Y, Sekido Y, Miao Y and Kondo Y: Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Oncogene. May 21–2012.(Epub ahead of print),. View Article : Google Scholar
16.	Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M and Sato Y: Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. Mol Cancer Res. 10:1135–1146. 2012. View Article : Google Scholar : PubMed/NCBI
17.	Huang Y, Gu B, Wu R, Zhang J, Li Y and Zhang M: Development of a rabbit monoclonal antibody group against Smads and immunocytochemical study of human and mouse embryonic stem cells. Hybridoma (Larchmt). 26:387–391. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Spieker-Polet H, Sethupathi P, Yam PC and Knight KL: Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc Natl Acad Sci USA. 92:9348–9352. 1995. View Article : Google Scholar : PubMed/NCBI
19.	Tan Z, Zhang J, Su Z, Gu B, Jiang X, Luo J, Ji H, Wang G, Tao B, Zhao X, Chen L, Yu G, Zhu W and Zhang M: Production of rabbit monoclonal antibodies against mouse embryonic stem cells and identification of pluripotency-associated surface antigens. J Immunol Methods. 365:149–157. 2011. View Article : Google Scholar : PubMed/NCBI
20.	Saradhi M, Krishna B, Mukhopadhyay G and Tyagi RK: Purification of full-length human pregnane and xenobiotic receptor: polyclonal antibody preparation for immunological characterization. Cell Res. 15:785–795. 2005. View Article : Google Scholar
21.	Chen TF, Zhang YL, Xu WL, Li ZQ, Hou B, Wang CL, Fan M, Qian LJ, Zhou RP and Zhang CG: Prokaryotic expression, polyclonal antibody preparation, and sub-cellular localization analysis of Na⁺, K⁺-ATPase beta2 subunit. Protein Expr Purif. 37:47–52. 2004. View Article : Google Scholar : PubMed/NCBI
22.	Crowther JR: ELISA. Theory and practice. Methods Mol Biol. 42:1–218. 1995.PubMed/NCBI
23.	Crowther JR: The ELISA guidebook. Methods Mol Biol. 149:III–IV. 1–413. 2000.PubMed/NCBI
24.	Tsumuraya T, Takeuchi K, Yamashita S, Fujii I and Hirama M: Development of a monoclonal antibody against the left wing of ciguatoxin CTX1B: thiol strategy and detection using a sandwich ELISA. Toxicon. 60:348–357. 2012. View Article : Google Scholar : PubMed/NCBI
25.	Tang S, Wang Y, Zhang D, Gao Y, Ma Y, Yin B, Sun J, Liu J and Zhang Y: Reprogramming donor cells with oocyte extracts improves in vitro development of nuclear transfer embryos. Anim ReprodSci. 115:1–9. 2009. View Article : Google Scholar : PubMed/NCBI
26.	Lin J, Lin X, Yang GH, Wang Y, Peng BW and Lin JY: Toxoplasma gondii: expression of GRA1 gene in endoplasmic reticulum promotes both growth and adherence and modulates intracellular calcium release in macrophages. Exp Parasitol. 125:165–171. 2010. View Article : Google Scholar : PubMed/NCBI
27.	Tan Z, Zhang J, Su Z, Gu B, Jiang X, Luo J, Ji H, Wang G, Tao B, Zhao X, Chen L, Yu G, Zhu W and Zhang M: Production of rabbit monoclonal antibodies against mouse embryonic stem cells and identification of pluripotency-associated surface antigens. J Immunol Methods. 365:149–157. 2011. View Article : Google Scholar : PubMed/NCBI
28.	Hama Y, Chano T, Inui T, Matsumoto K and Okabe H: Preparation of mouse monoclonal antibody for RB1CC1 and its clinical application. PLoS One. 7:e320522012. View Article : Google Scholar : PubMed/NCBI